NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,488 | -99.5% | 62,819 | +897.1% | 0.25% | +336.8% |
| Q4 2021 | $511,000 | +112.9% | 6,300 | +205.8% | 0.06% | +96.6% |
| Q3 2021 | $240,000 | -82.6% | 2,060 | -79.2% | 0.03% | -81.4% |
| Q1 2021 | $1,380,000 | +3.0% | 9,894 | +27.8% | 0.16% | -28.1% |
| Q4 2020 | $1,340,000 | -30.4% | 7,743 | -77.1% | 0.22% | -18.7% |
| Q3 2018 | $1,925,000 | +277.5% | 33,784 | +392.7% | 0.27% | +178.1% |
| Q2 2017 | $510,000 | -13.6% | 6,857 | +8.9% | 0.10% | -30.4% |
| Q1 2017 | $590,000 | +37.5% | 6,298 | +6.6% | 0.14% | +20.0% |
| Q4 2016 | $429,000 | – | 5,906 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |